BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 15766)

  • 1. Toxicology of ipecac: a review.
    Manno BR; Manno JE
    Clin Toxicol; 1977; 10(2):221-42. PubMed ID: 15766
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Death due to chronic syrup of ipecac use in a patient with bulimia.
    Schiff RJ; Wurzel CL; Brunson SC; Kasloff I; Nussbaum MP; Frank SD
    Pediatrics; 1986 Sep; 78(3):412-6. PubMed ID: 2875430
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies for the emetic mechanisms of ipecac syrup (TJN-119) and its active components in ferrets: involvement of 5-hydroxytryptamine receptors.
    Hasegawa M; Sasaki T; Sadakane K; Tabuchi M; Takeda Y; Kimura M; Fujii Y
    Jpn J Pharmacol; 2002 Jun; 89(2):113-9. PubMed ID: 12120752
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological aspects of ipecac syrup (TJN-119)-induced emesis in ferrets.
    Endo T; Nemoto M; Ogawa T; Tamakai H; Hamaue N; Hirafuji M; Takeda Y; Hasegawa M; Fugii Y; Minami M
    Res Commun Mol Pathol Pharmacol; 2000; 108(3-4):187-200. PubMed ID: 11913711
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urinary excretion of ipecac alkaloids in human volunteers.
    Yamashita M; Yamashita M; Azuma J
    Vet Hum Toxicol; 2002 Oct; 44(5):257-9. PubMed ID: 12361104
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Absorption, distribution and excretion of 3H-labeled cephaeline- and emetine-spiked ipecac syrup in rats.
    Asano T; Ishihara K; Wakui Y; Yanagisawa T; Kimura M; Kamei H; Yoshida T; Kuroiwa Y; Fujii Y; Yamashita M; Kuramochi T; Tomisawa H; Tateishi M
    Eur J Drug Metab Pharmacokinet; 2002; 27(1):17-27. PubMed ID: 11996323
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Single dose pharmacokinetics of syrup of ipecac.
    Scharman EJ; Hutzler JM; Rosencrance JG; Tracy TS
    Ther Drug Monit; 2000 Oct; 22(5):566-73. PubMed ID: 11034262
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biotransformation of the ipecac alkaloids cephaeline and emetine from ipecac syrup in rats.
    Asano T; Watanabe J; Sadakane C; Ishihara K; Hirakura K; Wakui Y; Yanagisawa T; Kimura M; Kamei H; Yoshida T; Fujii Y; Yamashita M
    Eur J Drug Metab Pharmacokinet; 2002; 27(1):29-35. PubMed ID: 11996324
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Toxic mechanisms of the heart: a review.
    Combs AB; Acosta D
    Toxicol Pathol; 1990; 18(4 Pt 1):583-96. PubMed ID: 2091237
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Position paper update: ipecac syrup for gastrointestinal decontamination.
    Höjer J; Troutman WG; Hoppu K; Erdman A; Benson BE; Mégarbane B; Thanacoody R; Bedry R; Caravati EM; ;
    Clin Toxicol (Phila); 2013 Mar; 51(3):134-9. PubMed ID: 23406298
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of emetic and United State pharmacopoeia ipecac syrup in prevention of drug absorption.
    Teshima D; Suzuki A; Otsubo K; Higuchi S; Aoyama T; Shimozono Y; Saita M; Noda K
    Chem Pharm Bull (Tokyo); 1990 Aug; 38(8):2242-5. PubMed ID: 1980639
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ipecac-induced myopathy simulating dermatomyositis.
    Bennett HS; Spiro AJ; Pollack MA; Zucker P
    Neurology; 1982 Jan; 32(1):91-4. PubMed ID: 6119651
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ipecac syrup abuse, morbidity, and mortality: isn't it time to repeal its over-the-counter status?
    Silber TJ
    J Adolesc Health; 2005 Sep; 37(3):256-60. PubMed ID: 16109351
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adverse effects of emetine therapy.
    Ramachandran S
    Ceylon Med J; 1973 Sep; 18(3):138-43. PubMed ID: 4793727
    [No Abstract]   [Full Text] [Related]  

  • 15. Position statement: ipecac syrup. American Academy of Clinical Toxicology; European Association of Poisons Centres and Clinical Toxicologists.
    Krenzelok EP; McGuigan M; Lheur P
    J Toxicol Clin Toxicol; 1997; 35(7):699-709. PubMed ID: 9482425
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Syrup of ipecac: a drug review.
    King WD
    Clin Toxicol; 1980 Oct; 17(3):353-8. PubMed ID: 6108822
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nonemetic effects of ipecac syrup.
    Czajka PA; Russell SL
    Pediatrics; 1985 Jun; 75(6):1101-4. PubMed ID: 2860632
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Absorption of ipecac alkaloids in emergency patients.
    Moran DM; Crouch DJ; Finkle BS
    Ann Emerg Med; 1984 Dec; 13(12):1100-2. PubMed ID: 6150666
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expired ipecac syrup efficacy.
    Grbcich PA; Lacouture PG; Kresel JJ; Russell MT; Lovejoy FH
    Pediatrics; 1986 Dec; 78(6):1085-9. PubMed ID: 2878409
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trends in ipecac use: a survey of poison center staff.
    Marchbanks B; Lockman P; Shum S; Beard D
    Vet Hum Toxicol; 1999 Feb; 41(1):47-8. PubMed ID: 9949488
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.